TARGETING CD2 FOR IMMUNOTHERAPY - RESULTS OF A PHASE-1 TRIAL WITH A LFA-3 IGG FE FUSION PROTEIN/

Citation
D. Magilavy et al., TARGETING CD2 FOR IMMUNOTHERAPY - RESULTS OF A PHASE-1 TRIAL WITH A LFA-3 IGG FE FUSION PROTEIN/, Journal of investigative dermatology, 110(4), 1998, pp. 682-682
Citations number
NO
Categorie Soggetti
Dermatology & Venereal Diseases
ISSN journal
0022202X
Volume
110
Issue
4
Year of publication
1998
Pages
682 - 682
Database
ISI
SICI code
0022-202X(1998)110:4<682:TCFI-R>2.0.ZU;2-P